Mulmit

Cogent Biosciences, Inc.Cogent Biosciences, Inc.

COGT Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2020-12-317,871,000-82,199,000-74,808,000
2019-12-3122,499,000-32,178,000-31,833,000
2018-12-319,734,000-36,005,000-34,532,000
2017-12-318,360,000-26,152,000-25,492,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-27Morris Arlene41,927
2026-08-27Morris Arlene3,583
2026-08-27Morris Arlene42,349
2026-08-27Morris Arlene3,161
2026-08-27Morris Arlene41,927
2026-08-27Morris Arlene3,583
2026-07-01Ferrante Karen Jean627
2026-06-09Shegog Todd17,901
2026-06-09Morris Arlene17,901
2026-06-09Ros Matthew17,901
2026-06-09Harwin Peter Evan17,901
2026-06-09Ferrante Karen Jean17,901

8-K events

FiledItems
2026-09-02Entry into a material agreement
2026-08-10Other events · Financial statements and exhibits
2026-08-10Results of operations · Financial statements and exhibits
2026-06-11Submission of matters to a vote
2026-05-05Results of operations · Financial statements and exhibits
2026-02-17Results of operations · Financial statements and exhibits
2025-12-08Other events
2025-11-18Entry into a material agreement · Creation of a direct financial obligation · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.